Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Renal Insufficiency Following Contrast Media Administration Trial II (Remedial II): The RenalGuard System in High-Risk Patients for Contrast-Induced Acute Kidney Injury

NCT01098032 is registered in ClinicalTrials.gov with Clinica Mediterranea as lead sponsor.

NCT NCT01098032
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01098032 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Renal Insufficiency Following Contrast Media Administration Trial II (Remedial II): The RenalGuard System in High-Risk Patients for Contrast-Induced Acute Kidney Injury
Lead sponsor
Clinica Mediterranea
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2009
Completion date
December 31, 2011
Enrollment
294 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney disease